Overview

Evaluation of Loratadine for Prevention of Pegfilgrastim-Induced Pain

Status:
Unknown status
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the incidence of pegfilgrastim-induced back and leg pain and to determine whether the antihistamine loratadine can prevent pegfilgrastim-induced back and leg pain.
Phase:
Phase 2
Details
Lead Sponsor:
University of Vermont
Collaborator:
Cancer and Leukemia Group B
Treatments:
Lenograstim
Loratadine